AC Immune
Bénédicte LE is a Clinical Project Manager at AC Immune since August 2017, with extensive experience in overseeing post-market clinical trials and managing clinical projects in various capacities at QuintilesIMS and Quintiles-Outcome. With a background in clinical project coordination and management at BIOTRONIK, Bénédicte has developed skills in site management, electronic data capture, and study management for cardiovascular devices. Previous research experience includes work as a trainee research engineer at Guerbet, focusing on in vitro screening of tumor biomarkers, and at CIRAD, where genetic diversity of phytopathogenic bacteria was characterized using bioinformatics. Bénédicte holds a Master's degree in bioengineering from Université de Technologie de Compiègne and a DEUG in Life Sciences from Faculté des Sciences de Reims.
This person is not in any offices
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.